NCT05033366

Brief Summary

The purpose of this study is to determine if certain patterns of hormone levels during the menstrual cycle are correlated with different pregnancy outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

July 30, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 2, 2021

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

4.1 years

First QC Date

July 30, 2021

Last Update Submit

March 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • self reported pregnancy

    Questionnaire used to assess if positive Proov test strips measuring urine PDG correlate with increased rates of self reported pregnancy

    Two menstrual cycle, up to 45 days each

Secondary Outcomes (1)

  • self reported first trimester pregnancy loss

    Three months

Study Arms (1)

Proov test strip users that record results with the Proov app

Participants using Proov test strips along with the Proov app who have logged at least one complete cycle will be asked to complete an online survey about fertility test results and current/previous pregnancy status. They will also be asked cycle history (irregular vs regular, cycle length), fertility testing (partners semen analysis results, AMH level, HSG results), possible fertility medications taken or prescribed, age, race, smoking status, and BMI.

Diagnostic Test: Proov Test

Interventions

Proov TestDIAGNOSTIC_TEST

Rapid response urine PdG, FSH, E1G and LH test strips, Proov

Proov test strip users that record results with the Proov app

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Females age 18 - no limit who are using, or have used, the Proov hormone test strips and the Proov app for at least one full cycle.

You may qualify if:

  • Female
  • Age 18 - no limit
  • Have completed one full cycle using the Proov app

You may not qualify if:

  • Male
  • Have not completed one full cycle using the Proov app

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MFB Fertility

Boulder, Colorado, 80301, United States

Location

Study Officials

  • Amy Beckely, PhD

    MFB Fertility

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2021

First Posted

September 2, 2021

Study Start

March 1, 2020

Primary Completion

April 1, 2024

Study Completion

April 1, 2026

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

only cohort data will be released

Locations